These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 7620950)

  • 1. The role of angioplasty to improve inflow for infrainguinal bypasses.
    Brewster DC
    Eur J Vasc Endovasc Surg; 1995 Apr; 9(3):262-6. PubMed ID: 7620950
    [No Abstract]   [Full Text] [Related]  

  • 2. Iliac angioplasty and stenting in association with infrainguinal bypasses: timing and techniques.
    Schneider PA
    Semin Vasc Surg; 2003 Dec; 16(4):291-9. PubMed ID: 14691771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of magnetic resonance angiography for the preoperative evaluation of patients with infrainguinal arterial occlusive disease.
    Hoch JR; Tullis MJ; Kennell TW; McDermott J; Acher CW; Turnipseed WD
    J Vasc Surg; 1996 May; 23(5):792-800; discussion 801. PubMed ID: 8667500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of surgical insults on restenosis after transluminal balloon angioplasty.
    Yasuhara H; Shigematsu H; Kobayashi I; Muto T
    Surg Today; 1995; 25(10):897-900. PubMed ID: 8574056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined percutaneous endovascular iliac angioplasty and infrainguinal surgical revascularization for chronic lower extremity ischemia: preliminary result.
    Mousa A; Abdel-Hamid M; Ewida A; Saad M; Sahrabi A
    Vascular; 2010; 18(2):71-6. PubMed ID: 20338130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipoprotein(a) and other serum lipid subfractions influencing primary patency after infrainguinal percutaneous transluminal angioplasty.
    Giovanetti F; Gargiulo M; Laghi L; D'Addato S; Maioli F; Muccini N; Borghi C; Stella A
    J Endovasc Ther; 2009 Jun; 16(3):389-96. PubMed ID: 19642794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hybrid surgical and endovascular therapy in multifocal peripheral TASC D lesions: up to three-year follow-up.
    Nishibe T; Kondo Y; Dardik A; Muto A; Koizumi J; Nishibe M
    J Cardiovasc Surg (Torino); 2009 Aug; 50(4):493-9. PubMed ID: 19734834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endovascular interventions in iliac and infrainguinal occlusive artery disease.
    Ruef J; Hofmann M; Haase J
    J Interv Cardiol; 2004 Dec; 17(6):427-35. PubMed ID: 15546296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Different methods of percutaneous desobstruction of peripheral arteries].
    Joffre F; Rousseau H; Cinqualbre A; Lapeyre F; Chemali R
    Arch Mal Coeur Vaiss; 1991 Nov; 84(11 Suppl):1711-20. PubMed ID: 1837445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regional angiotherapy by application of recombinant tissue-type plasminogen activator, followed by PTA and vascular endoprosthesis.
    Rinast E; Weiss HD
    Acta Radiol Suppl; 1991; 377():29-34. PubMed ID: 1666251
    [No Abstract]   [Full Text] [Related]  

  • 11. Guidelines for stenting in infrainguinal arterial disease.
    Tsetis D; Belli AM
    Cardiovasc Intervent Radiol; 2004; 27(3):198-203. PubMed ID: 15129334
    [No Abstract]   [Full Text] [Related]  

  • 12. [Stents in peripheral arterial occlusive diseases (PAOD)].
    Roeren T
    Ther Umsch; 2003 Apr; 60(4):199-203. PubMed ID: 12731429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infrainguinal occlusive disease: endovascular intervention is the first line therapy.
    Lee LK; Kent KC
    Adv Surg; 2008; 42():193-204. PubMed ID: 18953818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. When is urokinase treatment an effective sole or adjunctive treatment for acute limb ischemia secondary to native artery occlusion?
    Suggs WD; Cynamon J; Martin B; Sanchez LA; Wahl SI; Aronoff B; Veith FJ
    Am J Surg; 1999 Aug; 178(2):103-6. PubMed ID: 10487258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A ten-year experience with one hundred fifty failing or threatened vein and polytetrafluoroethylene arterial bypass grafts.
    Sanchez LA; Gupta SK; Veith FJ; Goldsmith J; Lyon RT; Wengerter KR; Panetta TF; Marin ML; Cynamon J; Berdejo G
    J Vasc Surg; 1991 Dec; 14(6):729-36; discussion 736-8. PubMed ID: 1835737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contemporary percutaneous treatment of infrapopliteal arterial disease: a practical approach.
    Golzar JA; Belur A; Carter LI; Choksi N; Safian RD; O'Neill WW
    J Interv Cardiol; 2007 Jun; 20(3):222-30. PubMed ID: 17524115
    [No Abstract]   [Full Text] [Related]  

  • 17. Regarding "comparing patency rates between external iliac and common iliac stents".
    Luján S; Criado E; Izquierdo LM; Puras E
    J Vasc Surg; 2001 Mar; 33(3):665-6. PubMed ID: 11241158
    [No Abstract]   [Full Text] [Related]  

  • 18. Two-year results after directional atherectomy of infrapopliteal arteries with the SilverHawk device.
    Zeller T; Sixt S; Schwarzwälder U; Schwarz T; Frank U; Bürgelin K; Pochert V; Müller C; Noory E; Krankenberg H; Hauswald K; Neumann FJ; Rastan A
    J Endovasc Ther; 2007 Apr; 14(2):232-40. PubMed ID: 17484535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Endovascular therapy in combination with conventional vascular surgery for the treatment of peripheral arterial obliterative disease].
    Gassel HJ; Kellersmann R; Franke S; Thiede A
    Zentralbl Chir; 2002 Feb; 127(2):99-104. PubMed ID: 11894210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Role of peripheral vascular angioplasty].
    Boccalon H
    Presse Med; 1993 Jun; 22(21):986-9. PubMed ID: 8367437
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.